Viewing Study NCT00956293


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2025-12-25 @ 11:28 PM
Study NCT ID: NCT00956293
Status: TERMINATED
Last Update Posted: 2014-06-06
First Post: 2009-08-07
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-07
Start Date Type: None
Primary Completion Date: 2013-03
Primary Completion Date Type: ACTUAL
Completion Date: 2013-03
Completion Date Type: ACTUAL
First Submit Date: 2009-08-07
First Submit QC Date: None
Study First Post Date: 2009-08-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-03-26
Results First Submit QC Date: None
Results First Post Date: 2014-05-12
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-05-23
Last Update Post Date: 2014-06-06
Last Update Post Date Type: ESTIMATED